基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
无可用的信号评分。
Explore the detailed record of transactions filed by Kingsley Stuart A, 董事. Director active across 1 company, notably Indivior Pharmaceuticals, Inc.. In total, 3 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €26k. Activity tracked since 26 January 2026. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Stuart A. Kingsley is a Board Member at Indivior Pharmaceuticals, Inc., a company specializing in addiction treatments. As a board member, he brings his expertise in strategy and governance to support the company's mission.